Athena Countouriotis Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Athena Countouriotis.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Athena Countouriotis. Athena Countouriotis is a SVP and Chief Medical Officer in HALOZYME THERAPEUTICS INC ($GYHT) and a Chief Medical Officer in AMBIT BIOSCIENCES CORP ($AMBI) and a Director in Trovagene, Inc. ($XNOM.OB) and a Director in IOVANCE BIOTHERAPEUTICS, INC. ($IOVA) and a SVP, Chief Medical Officer in Adverum Biotechnologies, Inc. ($ADVM) and a President & CEO in Turning Point Therapeutics, Inc. ($TPTX) and a Director in Passage BIO, Inc. ($PASG).

Address: C/O AMBIT BIOSCIENCES CORPORATION 11080 ROSELLE STREET SAN DIEGO 92121 CA

Companies in which Athena Countouriotis is an Insider

Adverum Biotechnologies, Inc.

Trading Symbol: ADVM
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Athena Countouriotis: SVP, Chief Medical Officer
Holdings: 150,000 shares
Latest Transaction: Feb 20 2018

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 150,000
Shares Sold: 0
Share Difference: +150,000
Value Difference: $0

AMBIT BIOSCIENCES CORP

Trading Symbol: AMBI
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Athena Countouriotis: Chief Medical Officer
Holdings: 0 shares
Latest Transaction: Nov 12 2014

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

HALOZYME THERAPEUTICS, INC.

Trading Symbol: GYHT
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Athena Countouriotis: SVP and Chief Medical Officer
Holdings: 45,977 shares
Latest Transaction: Feb 06 2017

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 2x
Shares Bought: 32,446
Shares Sold: 7,007
Share Difference: +25,439
Value Difference: +$85,517

IOVANCE BIOTHERAPEUTICS, INC.

Trading Symbol: IOVA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Athena Countouriotis: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 11 2019
$IOVA Market Capitalization: $437.71M
$IOVA Previous Close: $7.10

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Passage BIO, Inc.

Trading Symbol: PASG
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Athena Countouriotis: Director
Holdings: 18,900 shares
Latest Transaction: Mar 25 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 20,000
Shares Sold: 0
Share Difference: +20,000
Value Difference: -$299,500

Trovagene, Inc.

Trading Symbol: XNOM.OB
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Athena Countouriotis: Director
Holdings: 0 shares
Latest Transaction: Jun 24 2019

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Turning Point Therapeutics, Inc.

Trading Symbol: TPTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Athena Countouriotis: President & CEO
Holdings: 22,706 shares
Latest Transaction: Jan 08 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 22,706
Shares Sold: 0
Share Difference: +22,706
Value Difference: -$687,976

Latest Insider Trading Transactions of Athena Countouriotis

Sentiment: All, ADVM, AMBI, GYHT, IOVA, PASG, XNOM.OB, TPTX

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 25 2020PASGPassage BIO, Inc.Countouriotis AthenaDirectorBuyP14.9810,000149,75018,9008.9 K to 18.9 K (+112.36 %)
Mar 25 2020PASGPassage BIO, Inc.Countouriotis AthenaDirectorBuyP14.9810,000149,75018,9008.9 K to 18.9 K (+112.36 %)
Mar 02 2020PASGPassage BIO, Inc.Countouriotis AthenaDirectorOption ExerciseA18.0033,836609,04833,836
Jan 08 2020TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOOption ExerciseA63.33325,00020,582,250325,000
Jan 08 2020TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOGrantA31.1370621,97622,70622 K to 22.7 K (+3.21 %)
Sep 11 2019TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOBuyP45.0010,000450,00022,00012 K to 22 K (+83.33 %)
Jun 24 2019XNOM.OBTrovagene, Inc.Countouriotis AthenaDirectorOption ExerciseA2.4844,734110,94046,019

View all Athena Countouriotis insider transactions.